Cognitive Test Solution in Mice with Different Brain Weights after Atomoxetine

Area of Science:

• Neuroscience
• Pharmacology
• Animal Behavior

Background:

• Atomoxetine is a selective norepinephrine reuptake inhibitor.
• Mouse strain differences in brain weight may influence drug responses.
• Noradrenergic pathways are crucial for cognitive function and stress responses.

Purpose of the Study:

• To investigate the behavioral effects of daily atomoxetine administration in two mouse strains with differing relative brain weights.
• To explore potential strain-specific differences in responses to atomoxetine.
• To examine the impact of atomoxetine on cognitive performance and behavioral despair.

Main Methods:

• Two mouse strains with distinct relative brain weights were administered seven daily injections of atomoxetine.
• Performance was assessed using a puzzle-box cognitive test.
• Behavioral despair was evaluated in an aversive slippery funnel test (analogous to the Porsolt test).

Main Results:

• Atomoxetine differentially affected cognitive task performance based on mouse strain and brain size.
• Mice with larger brains were less successful in the cognitive test, potentially due to reduced fear.
• Atomoxetine-treated mice exhibited increased activity in the aversive test, with significantly decreased immobility time.
• Interstrain differences in behavioral reactions suggest variations in ascending noradrenergic projections.

Conclusions:

• Atomoxetine's effects on behavior are complex and influenced by relative brain weight.
• The observed behavioral differences suggest underlying disparities in the noradrenergic system between the mouse strains.
• Further research into the noradrenergic system and related drug effects in these strains is warranted.